Human mesenchymal stem cells (hMSCs) are multipotent cells, which exhibit plastic
adherence, express specific cell surface marker spectrum, and have multi‐lineage …

Regenerative medicine literature has proposed mesenchymal stem/progenitor cell‐(MSC‐)
mediated therapeutic approaches for their great potential in managing various diseases and …

Exosomes derived from mesenchymal stem cells (MSCs) have been considered as an
alternative for cell therapy of acute spinal cord injury (ASCI). However, the underlying …

Dental stem cells (DSCs), an important source of mesenchymal stem cells (MSCs), can be
easily obtained by minimally invasive procedures and have been used for the treatment of …

The therapeutic potential of the dental pulp stem (DSC) cell-derived secretome, consisting of
various biomolecules, is undergoing intense research. Despite promising in vitro and in vivo …

Preclinical and clinical studies with various stem cells, their secretomes, and extracellular
vesicles (EVs) indicate their use as a promising strategy for the treatment of various …

Neurodegenerative diseases represent a growing burden on healthcare systems worldwide.
Mesenchymal stem cells (MSCs) have shown promise as a potential therapy due to their …

Mesenchymal stem cells (MSCs) have the capacity for self-renewal and multilineage
differentiation potential, and are considered a promising cell population for cell-based …

Mesenchymal stem cells (MSCs) are known for their beneficial effects and regenerative
potential. In particular, dental-derived MSCs have the advantage of easier accessibility and …

Objectives Cleft lip and palate (CL/P) are common congenital orofacial anomalies.
Autogenous iliac bone grafting closes alveolar cleft defects but requires surgical …